Start for free
Start for free
TF

The Fink Family Office

Europe, England, United Kingdom, London

Description

The Fink Family Office operates as a family investment office.

Investor Profile

The Fink Family Office has made 6 investments, with 1 in the past 12 months and 33% as lead.

Stage Focus

  • Seed (67%)
  • Pre Seed (17%)
  • Series Unknown (17%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Medical
  • Chemical Engineering
  • Industrial Automation
  • Robotics
  • Biopharma
  • Pharmaceutical
  • Advanced Materials
  • Electronics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does The Fink Family Office frequently co-invest with?

DV
Dhyan VC
Europe, England, United Kingdom, London
Co-Investments: 1
Longevitytech.fund
Longevitytech.fund
North America, Florida, United States, Boca Raton
Co-Investments: 2
Elbow Beach Capital
Elbow Beach Capital
Europe, England, United Kingdom, London
Co-Investments: 3
Wren Capital
Wren Capital
Europe, England, United Kingdom, London
Co-Investments: 2
Oxford Technology Management
Oxford Technology Management
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 2
UK Innovation & Science Seed Fund
UK Innovation & Science Seed Fund
Europe, Oxfordshire, United Kingdom, Harwell
Co-Investments: 2
Future Planet Capital
Future Planet Capital
Europe, England, United Kingdom, London
Co-Investments: 1
Cur8 Capital
Cur8 Capital
Europe, England, United Kingdom, London
Co-Investments: 1
Britbots
Britbots
Europe, England, United Kingdom, London
Co-Investments: 1
Empirical Ventures
Empirical Ventures
Europe, Bristol, City of, United Kingdom, Bristol
Co-Investments: 6

What are some of recent deals done by The Fink Family Office?

Argonaute RNA

Bristol, Bristol, City of, United Kingdom

Argonaute RNA company research projects build on existing intellectual property.

Biotechnology
Series UnknownJul 17, 2024
Amount Raised: $2,270,086
MitoRx Therapeutics

Harwell, Oxfordshire, United Kingdom

MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.

BiotechnologyTherapeutics
SeedDec 13, 2023
Amount Raised: $5,048,523
EnsiliTech

Bath, Bath and North East Somerset, United Kingdom

EnsiliTech is a biopharmaceuticals company that preserves the integrity of vaccines and other biological materials.

BiopharmaMedicalPharmaceutical
Pre SeedJan 17, 2023
Amount Raised: $1,105,534
QV Bioelectronics

Manchester, Manchester, United Kingdom

Longer, Better Quality Lives for Brain Tumour Patients

Advanced MaterialsBiotechnologyElectronicsHealth CareLife ScienceMedicalMedical DeviceNanotechnologyNeuroscience
SeedJan 10, 2023
Amount Raised: $2,430,600
cheMastery

London, England, United Kingdom

CheMastery is a company that creates laboratory automation technology.

Chemical EngineeringIndustrial AutomationRobotics
SeedNov 13, 2022
MitoRx Therapeutics

Harwell, Oxfordshire, United Kingdom

MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.

BiotechnologyTherapeutics
SeedApr 25, 2022
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator